Allogene Therapeutics Inc (NAS:ALLO)
$ 2.095 0.015 (0.72%) Market Cap: 437.40 Mil Enterprise Value: 138.33 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 28/100

Allogene Therapeutics Inc Business Update- Conference Call Transcript

Oct 07, 2021 / 09:00PM GMT
Release Date Price: $24.38 (+1.71%)
Operator

Hello. Thank you for standing by for this conference call. (Operator Instructions) Thank you. Please be aware that today's conference call is being recorded.

I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.

Christine Cassiano
Allogene Therapeutics, Inc. - Chief Communications Officer

Thank you, operator, and thanks to all of you for joining today on short notice. After the market closed today, Allogene issued a press release that provides a clinical update on our AlloCAR T program. The press release and today's webcast are both available on our website.

Today's call will be led by Dr. David Chang, our President and Chief Executive Officer. During the Q&A, he'll be joined by Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; and Dr. Eric Schmidt, Chief Financial Officer.

We will do our best to get to as many questions as possible. As such, we ask you to limit questions to one per person so we can get to as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot